Microneedle array patches (MAPs) are a transformative innovation in drug delivery, with the potential to redefine how medications and vaccines reach patients. MAPs promise a simpler, more effective way to deliver a wide range of therapeutics, but their journey from concept to commercialization is filled with critical challenges. From scaling manufacturing to ensuring regulatory compliance, navigating these complexities is essential for success.
Download the webinar presentation to learn:
- The various types of MAPs and their clinical advantages
- Key characterization methods to ensure safety and efficacy, including analytical, performance, and preclinical assessments
- Techniques for evaluating skin penetration, delivery efficiency, and other critical factors
- How robust product evaluation can mitigate risks and accelerate clinical and commercial milestones
Download the Presentation
Fields marked with an * are required.